Helwan University
Clinical trials sponsored by Helwan University, explained in plain language.
-
Can a common antioxidant shield kidneys from a powerful antibiotic?
Disease control Not yet recruitingThis study tests whether taking alpha-lipoic acid, an antioxidant, can protect the kidneys of hospitalized patients who need the strong antibiotic colistin. Colistin can cause kidney damage, and researchers want to see if this supplement lowers that risk. The trial will involve 8…
Phase: PHASE3 • Sponsor: Helwan University • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New algorithm aims to prevent organ rejection in young kidney patients
Disease control Not yet recruitingThis study will develop a computer tool to help doctors give the right dose of tacrolimus to children who have received a kidney transplant. The goal is to keep tacrolimus levels in a safe and effective range, reducing the risk of the body rejecting the new kidney. Researchers wi…
Sponsor: Helwan University • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
New antibiotic dosing method could cut infections after heart surgery
Prevention Not yet recruitingThis study compares two ways of giving the antibiotic cefazolin during coronary artery bypass surgery to prevent wound infections. One group gets the drug as a steady drip (continuous infusion), the other as standard short injections. The trial will enroll 100 adults in Egypt and…
Phase: PHASE4 • Sponsor: Helwan University • Aim: Prevention
Last updated Jun 27, 2026 14:02 UTC
-
New study tests if a slow drip of antibiotics during surgery cuts infection risk
Prevention Not yet recruitingThis study compares two methods of giving the antibiotic cefazolin during orthopedic surgery to prevent surgical site infections. One group receives a continuous infusion during surgery, while the other gets the standard single dose before surgery. The trial will enroll 100 adult…
Phase: PHASE4 • Sponsor: Helwan University • Aim: Prevention
Last updated Jun 27, 2026 14:02 UTC